Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMB-3115 versus Stelara bioequivalence study in healthy Japanese adult males
jRCT2071210135Active, not recruiting
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Start
- Apr 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in psoriasis comparing DMB-3115 with Stelara 45 mg (2 arms). Primary endpoint: Pharmacokinetic profile comparison. Started Apr 2022; status: active, not recruiting.
02
Drugs
dmb-3115ustekinumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on jRCT2071210135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210135.